tm logo

Monitor this mark

View On USPTO

NAGLAZYME
Live/Registered
REGISTERED AND RENEWED

on 28 Sep 2015

Last Applicant/ Owned by

BioMarin Pharmaceutical Inc.

105 Digital Drive

Novato

CA

94949

Serial Number

78629370 filed on 13th May 2005

Registration Number

3132316 registered on 22nd Aug 2006

in the Principal Register

Correspondent Address

Gregory J. Chinlund

Gregory J. Chinlund

233 South Wacker Drive, Suite 6300

CHICAGO IL 60606-6357

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NAGLAZYME

pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders

First Use Date in General

08th Jun 2005

First Use Date in Commerce

08th Jun 2005

Mark Details

Serial Number

No 78629370

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 30610/61761

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Sep 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
28th Sep 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
28th Sep 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
28th Sep 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28th Aug 2015TEAS SECTION 8 & 9 RECEIVED
22nd Aug 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05th Apr 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05th Apr 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Apr 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Mar 2012TEAS SECTION 8 & 15 RECEIVED